(AOF) – Pfizer is expected to fall in pre-market on Wall Street after reducing its revenue forecasts for the whole year by 13% on Friday and announcing a savings plan of 3.5 billion dollars due to lower than expected sales of its anti-Covid-19 vaccine and treatment. Adjusted diluted earnings per share are expected between $1.45 and $1.65 for 2023 versus $3.25 to $3.45 initially forecast, for revenue expected between $58 and $61 billion versus $67 to $70 billion. initially planned.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
